Author

K. Wittwer

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

B. Sawatsky· 2 shared C. K. Pfaller· 2 shared A. A. Hennrich· 1 shared A. Schopf· 1 shared C. Riedel· 1 shared D. H. Banda· 1 shared G. Zimmer· 1 shared K.-K. Conzelmann· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

B. Sawatsky

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Non-neutralizing antibody responses to vesicular stomatitis virus-vectored influenza A virus vaccines correlate with protection

K. Wittwer, G. Zimmer, M. Rommel, Y. Krebs, S. Rezinciuc, B. Sawatsky, C. K. Pfaller

This study shows that non-neutralizing antibodies against conserved IAV antigens like NP and M2 provide cross-protection against different IAV strains in mice.

bioRxiv · Nov 2, 2022 · PreprintImmunology

Safe and effective two-in-one replicon-and-VLP minispike vaccine for COVID-19

A. A. Hennrich, D. H. Banda, M. Oberhuber, A. Schopf, V. Pfaffinger, K. Wittwer, B. Sawatsky, C. Riedel, C. K. Pfaller, K.-K. Conzelmann

This paper develops a safe and effective vaccine platform using rhabdovirus replicons that present the SARS-CoV-2 RBD as VLPs, inducing strong neutralizing antibodies in mice.

bioRxiv · Oct 2, 2020 · PreprintMicrobiology